A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease - The New England Journal of Medicine - 1997
Brief Summary:
Enoxaparin reduces the composite endpoint of death, MI, or recurrent angina at 14 days when compared to unfractionated heparin in the treatment of UA/NSTEMI.Reference:
http://www.ncbi.nlm.nih.gov/pubmed/9250846
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you